In conclusion, our study shows that TIIA can ameliorate inflammation and reduce hepatocyte apoptosis in NASH mice by inhibiting NET formation associated with MPO and CitH3 release, thereby reducing TNF-α, IL-6, and TGF-β expression. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatohepatitis.